AI assistant
Sending…
Tyra Biosciences, Inc. — Director's Dealing 2021
Sep 15, 2021
32575_dirs_2021-09-14_5b58716b-57c0-4144-8453-7e1cb7d31452.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Tyra Biosciences, Inc. (TYRA)
CIK: 0001863127
Period of Report: 2021-09-14
Reporting Person: Hudkins Robert L. (Chief Technology Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 270128 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $2.25 | 2031-03-09 | Common Stock (134937) | Direct |
Footnotes
F1: Includes 175,202 shares subject to repurchase by us, which are subject to vesting.
F2: 1/48th of the shares subject to the option vest monthly following March 5, 2021, the vesting commencement date.
More from Tyra Biosciences, Inc.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 2
Interim / Quarterly Report
2026
May 13
Earnings Release
2026
May 13
Annual Report
2026
Apr 17
Proxy Solicitation & Information Statement
2026
Apr 17
Board/Management Information
2026
Apr 17
Board/Management Information
2026
Apr 2
Regulatory Filings
2026
Mar 25
Director's Dealing
2026
Mar 17
Capital/Financing Update
2026
Mar 4